LNSR LENSAR, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$6.75
· of 52w range
· above low
· to high
$4.9552w low
$12.8452w high
Market Cap (MRQ)
$83M
P/E (TTM)
-22.5
EPS (TTM)
$-0.30
Revenue (TTM)
$60M
your badges
52W Range
$5–$13
Analyst Rating
BUY
Price Target
$11
P/E
-22.5
ROE
-851.7%
Net Profit Margin
57.6%
Your badge strip is empty — pin a metric anywhere on this page.
LNSR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.75
Market Cap (MRQ)
$83M
P/E (TTM)
-22.5
EPS (TTM)
$-0.30
Revenue (TTM)
$60M
ROE (TTM)
-851.7%
52W Range
$5–$13
LNSR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$58M2019-12-31 → 2025-12-31
EPS$-2.872021-12-31 → 2025-12-31
Free Cash Flow·2020-12-31 → 2023-12-31
Net margin57.6%2020-12-31 → 2023-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | LNSR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -22.55Y avg ≈-2.9 | ≈-2.9 | · | · | |
| P/S (TTM) | 1.45Y avg ≈1.3 | ≈1.3 | 2.1 | Undervalued | |
| P/B (MRQ) | 5.65Y avg ≈1.1 | ≈1.1 | 2.7 | Overvalued | |
| Price / Tangible Book (MRQ) | 8.25Y avg ≈1.5 | ≈1.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | LNSR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -13.5%5Y avg ≈-47.7% | ≈-47.7% | -39.8% | Top tier | |
| Net Profit Margin (TTM) | 57.6%5Y avg ≈-49.1% | ≈-49.1% | -44.3% | Top tier | |
| ROA (TTM) | 49.6%5Y avg ≈-27.5% | ≈-27.5% | -43.4% | In line | |
| ROE (TTM) | -851.7%5Y avg ≈-41.1% | ≈-41.1% | -41.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | LNSR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.45Y avg ≈4.0 | ≈4.0 | 3.8 | Low liquidity | |
| Quick Ratio (MRQ) | 1.05Y avg ≈2.8 | ≈2.8 | 3.2 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | LNSR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 9.2%5Y avg ≈17.7% | ≈17.7% | · | · | |
| Revenue CAGR 3Y | 18.2%5Y avg ≈17.0% | ≈17.0% | · | · | |
| Revenue CAGR 5Y | 17.2% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | LNSR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$389.6K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-393.8%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $0.10 | $-0.17 | 159.4% |
| March 31, 2026 | $0.00 | $0.19 | -100.0% | |
| Dec. 31, 2025 | $-0.12 | $-0.07 | -68.1% | |
| Sept. 30, 2025 | $-0.31 | $-0.05 | -507.8% | |
| June 30, 2025 | $-0.15 | $-0.08 | -96.1% | |
| March 31, 2025 | $-2.32 | $-0.16 | -1367.4% | |
| Dec. 31, 2024 | $-1.61 | $-0.18 | -776.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58M | $53M | $42M | $35M | $34M | $26M | $31M | |
| Cost of Revenue | $31M | $28M | $21M | $15M | $17M | $12M | $17M | |
| R&D Expense | $6M | $5M | $6M | $12M | $12M | $8M | $8M | |
| SG&A Expense | $45M | $26M | $26M | $27M | $24M | $24M | $17M | |
| Operating Income | $-25M | $-11M | $-12M | $-20M | $-20M | $-19M | $-13M | |
| Interest Expense | · | · | · | · | · | $1M | $2M | |
| Other Non-op | $636.0K | $660.0K | $698.0K | $263.0K | $51.0K | $68.0K | $58.0K | |
| Pretax Income | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | $-15M | |
| Net Income | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | $-15M | |
| EPS (Basic) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · | |
| EPS (Diluted) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · | |
| Shares (Basic) | 11,958,000 | 11,518,000 | 10,971,000 | 10,159,000 | 9,374,000 | · | · | |
| Shares (Diluted) | 11,958,000 | 11,518,000 | 10,971,000 | 10,159,000 | 9,374,000 | · | · | |
| EBITDA | · | · | $-12M | $-20M | $-20M | $-19M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $16M | $21M | $15M | $32M | $41M | $5M | |
| Short-term Investments | $5M | $6M | $3M | · | · | · | · | |
| Receivables | $6M | $6M | $4M | $6M | $5M | $2M | $3M | |
| Inventory | $22M | $11M | $16M | $12M | $6M | $13M | $8M | |
| Prepaid Expense | $601.0K | $2M | $2M | $1M | $2M | $2M | $618.0K | |
| Current Assets | $47M | $42M | $46M | $34M | $45M | $58M | $17M | |
| PP&E (Net) | $505.0K | $664.0K | $679.0K | $563.0K | $756.0K | $832.0K | $720.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $5M | $6M | $11M | $12M | $11M | $12M | $13M | |
| Other Non-current Assets | $3M | $3M | $2M | $3M | $3M | $4M | $1M | |
| Total Assets | $71M | $66M | $70M | $56M | $66M | $79M | $35M | |
| Accounts Payable | $19M | $6M | $4M | $5M | $3M | $2M | $2M | |
| Accrued Liabilities | $8M | $7M | $6M | $5M | $5M | $5M | $5M | |
| Current Liabilities | $41M | $15M | $12M | $11M | $9M | $8M | $8M | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $3M | $333.0K | |
| Other Non-current Liabilities | $909.0K | $702.0K | $570.0K | $167.0K | $69.0K | $129.0K | $310.0K | |
| Total Liabilities | $84M | $48M | $22M | $14M | $12M | $12M | $65M | |
| Common Stock | $120.0K | $116.0K | $113.0K | $111.0K | $110.0K | $109.0K | $11.0K | |
| Retained Earnings | $-178M | $-143M | $-112M | $-98M | $-78M | $-58M | $-38M | |
| AOCI | $4.0K | $6.0K | $4.0K | · | · | · | · | |
| Stockholders' Equity | $-26M | $5M | $33M | $42M | $55M | $67M | $-31M | |
| Liabilities + Equity | $71M | $66M | $70M | $56M | $66M | $79M | $35M | |
| Shares Outstanding | 11,993,000 | 11,654,000 | 11,327,000 | 11,093,000 | 10,990,000 | 10,933,000 | 1,070,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $6M | $7M | $7M | $9M | $102.0K | |
| Amort. of Intangibles | $921.0K | $970.0K | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-2M | $-10M | $-15M | $-9M | $-14M | $-13M | |
| CapEx | $83.0K | $156.0K | $236.0K | $115.0K | $354.0K | $366.0K | $389.0K | |
| Investing Cash Flow | $1M | $-2M | $-4M | $-115.0K | $-354.0K | $-326.0K | $-2M | |
| Stock Issued | · | · | · | · | · | $16M | · | |
| Net Stock Activity | · | · | · | · | · | $16M | · | |
| Financing Cash Flow | $10M | $78.0K | $20M | $-2M | $361.0K | $50M | $16M | |
| Net Change in Cash | $-3M | $-4M | $6M | $-17M | $-9M | $36M | $1M | |
| Taxes Paid | $42.0K | $24.0K | $18.0K | $3.0K | $19.0K | · | · | |
| Free Cash Flow | · | · | $-10M | $-15M | $-9M | $-14M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -29.0% | -57.1% | -57.0% | -70.1% | · | |
| Net Margin | · | · | -34.1% | -56.3% | -56.9% | -75.0% | · | |
| Pretax Margin | · | · | -34.1% | -56.3% | -56.9% | -75.0% | · | |
| EBITDA Margin | · | · | -29.0% | -57.1% | -57.0% | -70.1% | · | |
| ROA | · | · | -22.9% | -32.6% | -26.9% | -34.8% | · | |
| ROE | · | · | -41.2% | -47.1% | -35.0% | -29.0% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.0 | 3.0 | 5.1 | 6.9 | · | |
| Quick Ratio | · | · | 2.4 | 1.8 | 4.2 | 5.0 | · | |
| Interest Coverage | · | · | · | · | · | -13.8 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.7 | 0.6 | 0.5 | 0.5 | · | |
| Inventory Turnover | · | · | 1.5 | 1.7 | 1.7 | 1.1 | · | |
| Receivables Turnover | · | · | 8.4 | 6.6 | 10.4 | 9.8 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $2.95 | $3.78 | $4.99 | $6.15 | · | |
| Revenue / Share | · | · | $3.84 | $3.48 | · | · | · | |
| Cash Flow / Share | · | · | $-0.88 | $-1.46 | · | · | · | |
| Cash / Share | · | · | $1.82 | $1.32 | $2.88 | $3.71 | · | |
| EPS (TTM) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.2% | 26.9% | 19.2% | 2.6% | 30.6% | · | · | |
| Revenue CAGR 3Y | 18.2% | 15.8% | 16.9% | · | · | · | · | |
| Revenue CAGR 5Y | 17.2% | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $58M | $53M | $42M | $35M | $34M | $26M | · | |
| Net Income TTM | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | · | |
| Market Cap | · | · | $40M | $33M | $66M | $79M | · | |
| P/E | -4.1 | -3.3 | -2.7 | -1.5 | -2.9 | · | · | |
| P/S | · | · | 0.9 | 0.9 | 1.9 | 3.0 | · | |
| P/B | · | · | 1.2 | 0.8 | 1.2 | 1.2 | · | |
| P / Tangible Book | · | · | 1.8 | 1.1 | 1.5 | 1.4 | · | |
| P / Cash Flow | · | · | -4.1 | -2.2 | -7.3 | -5.7 | · | |
| P / FCF | · | · | -4.0 | -2.2 | -7.1 | -5.6 | · | |
| Earnings Yield | -24.7% | -30.5% | -37.3% | -66.2% | -34.9% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $13M | $16M | $14M | $14M | $14M | $17M | $14M | $13M | $11M | $12M | $10M | $12M | $8M | $10M | $8M | |
| Cost of Revenue | $7M | $7M | $9M | $8M | $7M | $7M | $10M | $7M | $6M | $5M | $7M | $5M | $5M | $4M | $4M | $4M | |
| R&D Expense | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $6M | $3M | $10M | $12M | $12M | $11M | $7M | $6M | $7M | $7M | $6M | $5M | $8M | $7M | $7M | $6M | |
| Operating Income | $2M | $2M | $-5M | $-8M | $-6M | $-6M | $-1M | $-1M | $-5M | $-3M | $-3M | $-2M | $-3M | $-4M | $-3M | $-4M | |
| Other Non-op | $171.0K | $145.0K | $151.0K | $133.0K | $193.0K | $159.0K | $149.0K | $153.0K | $160.0K | $198.0K | $233.0K | $265.0K | $111.0K | $89.0K | $123.0K | $92.0K | |
| Income Tax | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $4M | $36M | $-1M | $-4M | $-2M | $-27M | $-19M | $-2M | $-9M | $-2M | $-4M | $3M | $-9M | $-4M | $-2M | $-4M | |
| EPS (Basic) | $0.14 | $1.56 | $-0.09 | $-0.31 | $-0.15 | $-2.32 | $-1.62 | $-0.13 | $-0.79 | $-0.19 | $-0.23 | $0.13 | $-0.81 | $-0.40 | $-0.23 | $-0.39 | |
| EPS (Diluted) | $0.10 | $0.00 | $-0.09 | $-0.31 | $-0.15 | $-2.32 | $-1.62 | $-0.13 | $-0.79 | $-0.19 | $0.13 | $-0.23 | $-0.81 | $-0.40 | $-0.23 | $-0.39 | |
| Shares (Basic) | 12,297,000 | 12,161,000 | · | 12,044,000 | 11,937,000 | 11,774,000 | · | 11,604,000 | 11,451,000 | 11,387,000 | · | 11,102,000 | 10,820,000 | 10,716,000 | · | 10,225,000 | |
| Shares (Diluted) | 23,027,000 | 15,420,000 | · | 12,044,000 | 11,937,000 | 11,774,000 | · | 11,604,000 | 11,451,000 | 11,387,000 | · | 11,956,000 | 10,820,000 | 10,716,000 | · | 10,225,000 | |
| EBITDA | $2M | $2M | · | $-8M | $-6M | $-6M | · | $-1M | $-5M | $-3M | · | $-2M | $-3M | $-4M | · | $-4M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $12M | $13M | $8M | $7M | $20M | $16M | $10M | $8M | $14M | $21M | $25M | $25M | $8M | $15M | $19M | |
| Short-term Investments | $0 | $1M | $5M | $9M | $13M | $6M | $6M | $8M | $6M | $4M | $3M | · | · | · | · | · | |
| Receivables | $6M | $5M | $6M | $6M | $5M | $7M | $6M | $4M | $6M | $4M | $4M | $4M | $3M | $5M | $6M | $4M | |
| Inventory | $25M | $23M | $22M | $21M | $19M | $15M | $11M | $15M | $18M | $18M | $16M | $17M | $18M | $16M | $12M | $8M | |
| Prepaid Expense | $2M | $625.0K | $601.0K | $776.0K | $991.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $47M | $42M | $47M | $44M | $46M | $49M | $42M | $39M | $40M | $42M | $46M | $49M | $49M | $30M | $34M | $32M | |
| PP&E (Net) | $445.0K | $457.0K | $505.0K | $555.0K | $609.0K | $577.0K | $664.0K | $677.0K | $716.0K | $747.0K | $679.0K | $482.0K | $605.0K | $520.0K | $563.0K | $639.0K | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $11M | $11M | $11M | $12M | $12M | $12M | $12M | |
| Other Non-current Assets | $2M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| Total Assets | $70M | $66M | $71M | $70M | $70M | $73M | $66M | $62M | $61M | $66M | $70M | $71M | $71M | $52M | $56M | $55M | |
| Accounts Payable | $11M | $10M | $19M | $15M | $11M | $8M | $6M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | |
| Accrued Liabilities | $5M | $4M | $8M | $8M | $6M | $7M | $7M | $6M | $4M | $4M | $6M | $5M | $4M | $3M | $5M | $5M | |
| Current Liabilities | $20M | $18M | $41M | $36M | $30M | $27M | $15M | $12M | $10M | $10M | $12M | $11M | $11M | $10M | $11M | $10M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Liabilities | $874.0K | $815.0K | $909.0K | $911.0K | $544.0K | $616.0K | $702.0K | $205.0K | $262.0K | $537.0K | $570.0K | $560.0K | $568.0K | $360.0K | $167.0K | $22.0K | |
| Total Liabilities | $41M | $42M | $84M | $82M | $80M | $81M | $48M | $25M | $24M | $21M | $22M | $21M | $25M | $13M | $14M | $12M | |
| Common Stock | $123.0K | $121.0K | $120.0K | $119.0K | $119.0K | $118.0K | $116.0K | $116.0K | $115.0K | $114.0K | $113.0K | $112.0K | $112.0K | $111.0K | $111.0K | $110.0K | |
| Retained Earnings | $-138M | $-141M | $-178M | $-176M | $-172M | $-171M | $-143M | $-125M | $-123M | $-114M | $-112M | $-108M | $-111M | $-102M | $-98M | $-95M | |
| AOCI | $0 | $0 | $4.0K | $5.0K | $-3.0K | $3.0K | $6.0K | $15.0K | $-6.0K | $-1.0K | $4.0K | · | · | · | · | · | |
| Stockholders' Equity | $15M | $11M | $-26M | $-26M | $-23M | $-22M | $5M | $23M | $24M | $32M | $33M | $36M | $33M | $39M | $42M | $43M | |
| Liabilities + Equity | $70M | $66M | $71M | $70M | $70M | $73M | $66M | $62M | $61M | $66M | $70M | $71M | $71M | $52M | $56M | $55M | |
| Shares Outstanding | 12,282,000 | 12,101,000 | 11,993,000 | 11,935,000 | 11,933,000 | 11,790,000 | 11,654,000 | 11,612,000 | 11,544,000 | 11,395,000 | 11,327,000 | 11,246,000 | 11,199,000 | 11,103,000 | 11,093,000 | 11,023,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $347.0K | $690.0K | $873.0K | $850.0K | $766.0K | $654.0K | $662.0K | $668.0K | $683.0K | $652.0K | $816.0K | $1M | $2M | $2M | $2M | $2M | |
| Amort. of Intangibles | $228.0K | $229.0K | $230.0K | $229.0K | $230.0K | $232.0K | $232.0K | $232.0K | $232.0K | $274.0K | $273.0K | $273.0K | $275.0K | $276.0K | $276.0K | $276.0K | |
| Operating Cash Flow | $-127.0K | $-4M | $618.0K | $-4M | $-5M | $-7M | $4M | $3M | $-4M | $-5M | $-480.0K | $-339.0K | $-2M | $-7M | $-5M | $-5M | |
| CapEx | · | · | $0 | $0 | $77.0K | $6.0K | $3.0K | $20.0K | $113.0K | $20.0K | $45.0K | $2.0K | $181.0K | $8.0K | $57.0K | $2.0K | |
| Investing Cash Flow | $965.0K | $4M | $4M | $4M | $-7M | $531.0K | $2M | $-905.0K | $-2M | $-1M | $-4M | $-2.0K | $-181.0K | $-8.0K | $-57.0K | $-2.0K | |
| Financing Cash Flow | $233.0K | $-209.0K | $474.0K | $0 | $93.0K | $10M | $172.0K | $-93.0K | $129.0K | $-130.0K | $146.0K | $-205.0K | · | · | $196.0K | $-1M | |
| Net Change in Cash | $1M | $-480.0K | $5M | $487.0K | $-12M | $3M | $6M | $2M | $-6M | $-7M | $-4M | $-546.0K | $17M | $-7M | $-5M | $-6M | |
| Taxes Paid | · | · | $0 | · | · | · | $2.0K | $0 | · | · | $0 | $0 | $17.0K | $1.0K | $-7.0K | $0 | |
| Free Cash Flow | · | · | · | · | · | $-7M | · | · | · | $-5M | · | · | · | $-7M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.9% | 16.7% | · | -52.9% | -45.1% | -40.9% | · | -9.2% | -41.8% | -26.9% | · | -20.8% | -23.9% | -52.8% | · | -52.7% | |
| Net Margin | 21.4% | 270.6% | · | -25.9% | -12.7% | -193.1% | · | -11.1% | -71.6% | -20.4% | · | 26.2% | -72.9% | -51.8% | · | -51.5% | |
| EBITDA Margin | 12.9% | 16.7% | · | -52.9% | -45.1% | -40.9% | · | -9.2% | -41.8% | -26.9% | · | -20.8% | -23.9% | -52.8% | · | -52.7% | |
| ROA | 5.1% | 52.2% | · | -5.6% | -2.7% | -39.3% | · | -2.3% | -13.6% | -3.6% | · | 4.1% | -13.5% | -7.6% | · | -6.5% | |
| ROE | -86.8% | -640.2% | · | 234.3% | -594.9% | -564.2% | · | -5.1% | -32.1% | -6.0% | · | 6.5% | -22.6% | -9.6% | · | -8.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.4 | · | 1.2 | 1.5 | 1.8 | · | 3.4 | 3.9 | 4.1 | · | 4.4 | 4.7 | 3.0 | · | 3.3 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.6 | 0.8 | 1.2 | · | 1.9 | 1.9 | 2.1 | · | 2.6 | 2.7 | 1.3 | · | 2.3 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.0 | 2.3 | · | 2.8 | 2.6 | 2.6 | · | 3.3 | 2.8 | 2.4 | · | 2.6 | 4.0 | 2.0 | · | 2.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.21 | $0.89 | · | $-2.17 | $-1.93 | $-1.88 | · | $1.96 | $2.05 | $2.79 | · | $3.24 | $2.92 | $3.55 | · | $3.86 | |
| Revenue / Share | $0.72 | $0.87 | · | $1.19 | $1.17 | $1.20 | · | $1.17 | $1.10 | $0.93 | · | $0.82 | $1.11 | $0.77 | · | $0.76 | |
| Cash Flow / Share | · | $-0.28 | · | · | · | $-0.59 | · | · | · | $-0.47 | · | · | · | $-0.62 | · | · | |
| Cash / Share | $1.10 | $1.03 | · | $0.64 | $0.60 | $1.66 | · | $0.90 | $0.72 | $1.22 | · | $2.22 | $2.27 | $0.72 | · | $1.75 | |
| EPS (TTM) | $-0.30 | $-0.55 | · | $-4.40 | $-4.22 | $-4.86 | · | $-0.98 | $-1.08 | $-1.10 | · | $-1.67 | $-1.83 | $-1.69 | · | $-2.13 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $60M | $58M | · | $59M | $58M | $57M | · | $49M | $45M | $44M | · | $40M | $38M | $34M | · | $36M | |
| Net Income TTM | $35M | $29M | · | $-52M | $-49M | $-57M | · | $-17M | $-13M | $-12M | · | $-13M | $-20M | $-18M | · | $-21M | |
| Market Cap | $70M | $72M | · | $147M | $157M | $166M | · | $53M | $52M | $39M | · | $35M | $48M | $28M | · | $61M | |
| P/E | -19.0 | -10.8 | · | -2.8 | -3.1 | -2.9 | · | -4.7 | -4.2 | -3.1 | · | -1.9 | -2.3 | -1.5 | · | -2.6 | |
| P/S | 1.2 | 1.2 | · | 2.5 | 2.7 | 2.9 | · | 1.1 | 1.2 | 0.9 | · | 0.9 | 1.2 | 0.8 | · | 1.7 | |
| P/B | 4.7 | 6.7 | · | -5.7 | -6.8 | -7.5 | · | 2.3 | 2.2 | 1.2 | · | 1.0 | 1.5 | 0.7 | · | 1.4 | |
| P / Tangible Book | 6.9 | 12.4 | · | · | · | · | · | 3.2 | 3.0 | 1.8 | · | 1.4 | 2.3 | 1.0 | · | 2.0 | |
| P / Cash Flow | · | -16.9 | · | · | · | -24.0 | · | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| Earnings Yield | -5.2% | -9.2% | · | -35.6% | -32.0% | -34.4% | · | -21.4% | -24.0% | -32.4% | · | -54.0% | -43.1% | -67.9% | · | -38.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $58M | $53M | $42M | $35M | $34M |
| Operating Margin % | · | · | -29.0% | -57.1% | -57.0% |
| Net Income | $-34M | $-31M | $-14M | $-20M | $-20M |
| Diluted EPS | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | · | · | 4.0 | 3.0 | 5.1 |
| Quick Ratio | · | · | 2.4 | 1.8 | 4.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | $-10M | $-15M | $-9M |
Institutional owners (13F) 81 filers · $31.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
81
Value held
$31.0M
New positions
18
Exited positions
29
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 18 (-8 vs prior Q) | 29 (+20 vs prior Q) | 19 (-12 vs prior Q) | 20 (+5 vs prior Q) | -831K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | $6,140,534 | 1,075,400 | 19.80% | Shares |
| VANGUARD GROUP INC | $5,997,881 | 515,725 | 19.34% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,300,022 | 402,806 | 7.42% | Shares |
| Groupe la Francaise | $1,219,296 | 213,537 | 3.93% | Shares |
| RBF Capital, LLC | $1,077,254 | 188,661 | 3.47% | Shares |
| BlackRock, Inc. | $1,056,539 | 185,033 | 3.41% | Shares |
| CSS LLC/IL | $933,300 | 163,450 | 3.01% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $865,687 | 151,609 | 2.79% | Shares |
| CREDIT INDUSTRIEL ET COMMERCIAL | $824,290 | 144,359 | 2.66% | Shares |
| Kerrisdale Advisers, LLC | $795,917 | 139,390 | 2.57% | Shares |
| MILLENNIUM MANAGEMENT LLC | $689,083 | 120,680 | 2.22% | Shares |
| DCF Advisers, LLC | $675,019 | 118,217 | 2.18% | Shares |
| Evernest Financial Advisors, LLC | $674,351 | 118,100 | 2.17% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $653,221 | 114,331 | 2.11% | Shares |
| UBS Group AG | $488,970 | 85,634 | 1.58% | Shares |
| Yakira Capital Management, Inc. | $475,574 | 83,288 | 1.53% | Shares |
| STATE STREET CORP | $462,413 | 80,983 | 1.49% | Shares |
| Man Group plc | $445,164 | 77,962 | 1.44% | Shares |
| Alpine Global Management, LLC | $340,139 | 59,569 | 1.10% | Shares |
| GOLDMAN SACHS GROUP INC | $339,911 | 59,529 | 1.10% | Shares |
| GABELLI FUNDS LLC | $336,890 | 59,000 | 1.09% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $330,215 | 57,831 | 1.07% | Shares |
| Dynamic Technology Lab Private Ltd | $309,000 | 54,166 | 1.00% | Shares |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $304,103 | 53,258 | 0.98% | Shares |
| Centiva Capital, LP | $281,229 | 49,252 | 0.91% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $252,696 | 44,255 | 0.81% | Shares |
| CITADEL ADVISORS LLC | $204,115 | 35,747 | 0.66% | Shares |
| CITADEL ADVISORS LLC | $203,276 | 35,600 | 0.66% | Put option |
| GAMCO INVESTORS, INC. ET AL | $188,430 | 33,000 | 0.61% | Shares |
| LPL Financial LLC | $180,824 | 31,668 | 0.58% | Shares |
| Quinn Opportunity Partners LLC | $167,583 | 29,349 | 0.54% | Shares |
| GTS SECURITIES LLC | $142,773 | 25,004 | 0.46% | Shares |
| Cresset Asset Management, LLC | $142,750 | 25,000 | 0.46% | Shares |
| ROYAL BANK OF CANADA | $134,000 | 23,464 | 0.43% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $133,169 | 23,322 | 0.43% | Shares |
| NORTHERN TRUST CORP | $125,717 | 22,017 | 0.41% | Shares |
| JANE STREET GROUP, LLC | $116,273 | 20,363 | 0.38% | Shares |
| Carlson Capital, L.P. | $114,200 | 20,000 | 0.37% | Shares |
| Qube Research & Technologies Ltd | $106,052 | 18,573 | 0.34% | Shares |
| Sanctuary Advisors, LLC | $95,911 | 16,797 | 0.31% | Shares |
| Atria Investments, Inc | $86,695 | 15,183 | 0.28% | Shares |
| Murchinson Ltd. | $75,503 | 13,223 | 0.24% | Shares |
| Engineers Gate Manager LP | $63,324 | 11,090 | 0.20% | Shares |
| JANE STREET GROUP, LLC | $62,810 | 11,000 | 0.20% | Call option |
| &PARTNERS | $60,263 | 10,554 | 0.19% | Shares |
| Bank of New York Mellon Corp | $57,606 | 10,089 | 0.19% | Shares |
| Skandinaviska Enskilda Banken AB (publ) | $57,100 | 10,000 | 0.18% | Shares |
| Russell Investments Group, Ltd. | $56,204 | 9,843 | 0.18% | Shares |
| MORGAN STANLEY | $48,491 | 8,492 | 0.16% | Shares |
| FMR LLC | $18,209 | 3,189 | 0.06% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| North Run Capital, LP, North Run Advisors, LLC, NR-GRI Partners, LP, NR-GRI Partners GP, LP, ELLIS THOMAS B, HAMMER TODD B ×2 filings | March 25, 2025 | 55.90% | Amendment | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 13 insiders · 4 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Nicholas T Curtis | Chief Executive Officer | June 3, 2026 A | 1,122,758 | 0 | 0 | $0 |
| Thomas R Staab II | Chief Financial Officer | May 6, 2026 F | 174,609 | 0 | 0 | $0 |
| Alan B. Connaughton | Chief Operating Officer | June 3, 2026 A | 389,173 | 0 | 0 | $0 |
| Kendra Wong | Principal Accounting Officer | June 3, 2026 A | 56,481 | 0 | 0 | $0 |
| Gary M Winer | Director | June 3, 2026 A | 105,635 | 0 | 0 | $0 |
| Elizabeth G. O'Farrell | Director | June 3, 2026 A | 67,368 | 0 | 0 | $0 |
| HAMMER TODD B | Director | June 3, 2026 A | 56,083 | 0 | 0 | $0 |
| Thomas B Ellis | Director | June 3, 2026 A | 56,083 | 0 | 0 | $0 |
| Richard L Lindstrom MD | Director | June 3, 2026 A | 263,831 | 0 | 0 | $0 |
| William J Link PHD | Director | June 3, 2026 A | 568,062 | 0 | 0 | $0 |
| Aimee S Weisner | Director | June 3, 2026 A | 110,368 | 0 | 0 | $0 |
| John Peter Mclaughlin | Director | May 25, 2023 A | 53,631 | 0 | 0 | $0 |
| PDL BIOPHARMA, INC. | 10% owner | Oct. 1, 2020 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 5 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.02% | 32,301 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 16,558 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 114,491 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 275,971 SH | Aug. 19, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.00% | 4 NS | July 31, 2026 | N-PORT |
LNSR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$11.00
+63.0%
3 37.5%
Strong Buy
4 50.0%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-03Mean target $11.33 +67.9%
← Below all targets
Current price $6.75
Low$10.00
Mean$11.33
High$13.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| LNSR | · | -4.1 | 9.2% | · | · | · |
| ECOR | $36M | -2.7 | 27.2% | -43.6% | 4686.6% | 86.8% |
| HYPR | · | -2.3 | 5.2% | -262.3% | -93.5% | 49.8% |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026